Register for the T-Cell Engager Therapeutics Summit Europe
Please select the appropriate price when booking. Bookings are subject to approval.
All prices are shown in GBP.
Register by Friday, 19 September & Save up to £1,100
Drug Developer Pricing*
Conference + Workshop Day
(Save £1,100)
£2,497
On the Door: £3,597
Conference Only
(Save £700)
£1,899
On the Door: £2,599
Academic Pricing**
Conference + Workshop Day
(Save £1,100)
£1,897
On the Door: £2,997
Conference Only
(Save £700)
£1,499
On the Door: £2,199
Solution Providers Pricing***
Conference + Workshop Day
(Save £1,100)
£3,197
On the Door: £4,297
Conference Only
(Save £700)
£2,399
On the Door: £3,099
* To be eligible for this price, the group or individuals must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services.
** To be eligible for this price, the group or individual must be full-time academic(s).
*** If you are a solution or service provider, have you considered sponsoring this event? Sponsorship includes multiple passes at a discounted rate. Inquire to learn more.
Unlock Group Discounts
Maximize value for money using special team discounts: Please note that discounts are only valid when three or more delegates from one company book and pay at the same time.
10% Off
When registering 2 attendees from one company
15% Off
When registering 3 attendees from one company
20% Off
When registering 4+ attendees from one company
Need Assistance?
If you have any questions about registration pricing, discounts or would like help in the booking process, contact us and one of the team will get back to you.
Explore the Full Event Guide
- Benchmark the latest clinical and preclinical insights shaping next-generation TCE development in oncology and autoimmunity
- Translate innovative design strategies, from co-stimulation to masked and logic-gated TCEs into improved specificity, potency, and safety
- Equip yourself with solutions to overcome translational and preclinical challenges, including hyperactivated T cells and unrealistic tumour clearance models
- Connect with leading biopharma, biotech, and academic pioneers driving novel modalities such as TITAN nanobodies, MAIT engagers, and NK cell engagers
- Position your team at the forefront of emerging therapeutic opportunities, with firsthand insights into investment trends, partnerships, and expansion into autoimmune disease
